The FDA approved 22 new drugs and biologics for the year 2016. These numbers are about half of the 45 new drugs and biologics approved for the year 2015. We will see how these medications perform versus established treatment paradigms. As always, I am hopeful for better outcomes/symptom/disease management and earlier detection where it applies. Of course, I will likely more closely follow the outcomes of the drugs used in oncology since radiation oncology is my discipline of choice.